These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 1283391

  • 1. Hydroxyurea and sickle cell disease.
    Orringer EP, Parker JC.
    Hematol Pathol; 1992; 6(4):171-8. PubMed ID: 1283391
    [No Abstract] [Full Text] [Related]

  • 2. Sickle cell pain & hydroxyurea.
    Day SW, Wynn LW.
    Am J Nurs; 2000 Nov; 100(11):34-8; quiz 38-9. PubMed ID: 11103633
    [No Abstract] [Full Text] [Related]

  • 3. Stimulation of fetal hemoglobin production by hydroxyurea in sickle cell anemia.
    Dover GJ, Charache S.
    Prog Clin Biol Res; 1989 Nov; 316B():295-306. PubMed ID: 2482499
    [No Abstract] [Full Text] [Related]

  • 4. Hydroxyurea in sickle cell disease.
    Schechter AN, Rodgers GP.
    N Engl J Med; 1996 Feb 01; 334(5):333. PubMed ID: 8532042
    [No Abstract] [Full Text] [Related]

  • 5. Concordant fetal hemoglobin response to hydroxyurea in siblings with sickle cell disease.
    Steinberg MH, Voskaridou E, Kutlar A, Loukopoulos D, Koshy M, Ballas SK, Castro O, Barton F.
    Am J Hematol; 2003 Feb 01; 72(2):121-6. PubMed ID: 12555216
    [Abstract] [Full Text] [Related]

  • 6. Hydroxyurea increases fetal hemoglobin production in sickle cell anemia.
    Platt OS, Orkin SH, Dover G, Beardsley GP, Miller B, Nathan DG.
    Trans Assoc Am Physicians; 1984 Feb 01; 97():268-74. PubMed ID: 6085528
    [No Abstract] [Full Text] [Related]

  • 7. Increasing fetal hemoglobin in sickle cell disease: comparisons of 5-azacytidine (subcutaneous or oral) with hydroxyurea.
    Dover GJ, Charache S, Boyer SH.
    Trans Assoc Am Physicians; 1984 Feb 01; 97():140-5. PubMed ID: 6085527
    [No Abstract] [Full Text] [Related]

  • 8. Induction of fetal hemoglobin in sickle cell patients by hydroxyurea: the N.I.H. experience.
    Rodgers GP, Dover GJ, Noguchi CT, Schechter AN, Nienhuis AW.
    Prog Clin Biol Res; 1989 Feb 01; 316B():281-93. PubMed ID: 2482498
    [No Abstract] [Full Text] [Related]

  • 9. Fetal hemoglobin, sickling, and sickle cell disease.
    Charache S.
    Adv Pediatr; 1990 Feb 01; 37():1-31. PubMed ID: 1702260
    [Abstract] [Full Text] [Related]

  • 10. Sickle cell anemia: targeting the role of fetal hemoglobin in therapy.
    Coleman E, Inusa B.
    Clin Pediatr (Phila); 2007 Jun 01; 46(5):386-91. PubMed ID: 17556734
    [Abstract] [Full Text] [Related]

  • 11. Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece.
    Loukopoulos D, Voskaridou E, Kalotychou V, Schina M, Loutradi A, Theodoropoulos I.
    Blood Cells Mol Dis; 2000 Oct 01; 26(5):453-66. PubMed ID: 11112383
    [Abstract] [Full Text] [Related]

  • 12. Pharmacologic manipulation of fetal hemoglobin levels in sickle cell diseases and thalassemia: promise and reality.
    Pearson HA.
    Adv Pediatr; 1996 Oct 01; 43():309-34. PubMed ID: 8794181
    [No Abstract] [Full Text] [Related]

  • 13. Therapies to increase fetal hemoglobin in sickle cell disease.
    Steinberg MH.
    Curr Hematol Rep; 2003 Mar 01; 2(2):95-101. PubMed ID: 12901139
    [Abstract] [Full Text] [Related]

  • 14. Spectrum of fetal hemoglobin responses in sickle cell patients treated with hydroxyurea: the National Institutes of Health experience.
    Rodgers GP.
    Semin Oncol; 1992 Jun 01; 19(3 Suppl 9):67-73. PubMed ID: 1379375
    [Abstract] [Full Text] [Related]

  • 15. Modulation of erythrocyte arginase activity in sickle cell disease patients during hydroxyurea therapy.
    Iyamu EW, Cecil R, Parkin L, Woods G, Ohene-Frempong K, Asakura T.
    Br J Haematol; 2005 Nov 01; 131(3):389-94. PubMed ID: 16225659
    [Abstract] [Full Text] [Related]

  • 16. Hydroxyurea therapy: improving the lives of patients with sickle cell disease.
    Anderson N.
    Pediatr Nurs; 2006 Nov 01; 32(6):541-3. PubMed ID: 17256291
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The biophysics of sickle cell hydroxyurea therapy.
    Eaton WA, Hofrichter J.
    Science; 1995 May 26; 268(5214):1142-3. PubMed ID: 7539154
    [No Abstract] [Full Text] [Related]

  • 19. Additive effect of sirolimus and hydroxycarbamide on fetal haemoglobin level in kidney transplant patients with sickle cell disease.
    Al-Khatti AA, Alkhunaizi AM.
    Br J Haematol; 2019 Jun 26; 185(5):959-961. PubMed ID: 30407620
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.